Director Omnibus Decision – 9 IPRsSeptember 2, 2026
Notice of Decisions on Institution — 2026-09-02
Patent Trial and Appeal Board
Total Proceedings
9
in this notice
Total Denied
1
discretionary + merits
Total Instituted
8
trial granted
Grant Rate
89%
11% denial rate
Trial Instituted· 8 proceedings
PGR2026-00032PGR2026-00033IPR2026-00274IPR2026-00326IPR2026-00275IPR2026-00271IPR2026-00273IPR2026-00272
Institution Denied· 1 proceeding
IPR2026-00304
Note
The USPTO Director issued an omnibus institution notice covering multiple proceedings. Written opinions may follow for selected cases.
- PTAB Director Review · Oct. 8, 2026Notice of Decisions on Institution — 2026-10-08
- PTAB Director Review · Sept. 24, 2026Biocon Biologics Limited et al. v. Regeneron Pharmaceuticals, Inc.
- PTAB Director Review · Sept. 23, 2026Notice of Decisions on Institution — 2026-09-23
- PTAB Director Review · Sept. 23, 2026Nearmap US, Inc. v. Eagle View Technologies, Inc.
- PTAB Director Review · Sept. 9, 2026Notice of Decisions on Institution — 2026-09-09